BRPI0511897A - método para tratar distúrbios de glándula sebácea hiperativa, e, uso de uma composição fotossensibilizadora hidrofóbica e/ou lipofìlica - Google Patents
método para tratar distúrbios de glándula sebácea hiperativa, e, uso de uma composição fotossensibilizadora hidrofóbica e/ou lipofìlicaInfo
- Publication number
- BRPI0511897A BRPI0511897A BRPI0511897-2A BRPI0511897A BRPI0511897A BR PI0511897 A BRPI0511897 A BR PI0511897A BR PI0511897 A BRPI0511897 A BR PI0511897A BR PI0511897 A BRPI0511897 A BR PI0511897A
- Authority
- BR
- Brazil
- Prior art keywords
- hydrophobic
- lipophilic
- gland disorders
- sebaceous gland
- photosensitizing composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002470403A CA2470403A1 (en) | 2004-02-06 | 2004-06-09 | Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders |
| PCT/CA2005/000154 WO2005120572A1 (en) | 2004-06-09 | 2005-02-08 | Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied hydrophobic green porphyrins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0511897A true BRPI0511897A (pt) | 2008-01-15 |
Family
ID=37649609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0511897-2A BRPI0511897A (pt) | 2004-06-09 | 2005-02-08 | método para tratar distúrbios de glándula sebácea hiperativa, e, uso de uma composição fotossensibilizadora hidrofóbica e/ou lipofìlica |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1755676B1 (https=) |
| JP (1) | JP2008501727A (https=) |
| AU (1) | AU2005251395A1 (https=) |
| BR (1) | BRPI0511897A (https=) |
| CA (1) | CA2568744A1 (https=) |
| DK (1) | DK1755676T3 (https=) |
| ES (1) | ES2400566T3 (https=) |
| MX (1) | MX2007000338A (https=) |
| NZ (1) | NZ551636A (https=) |
| WO (1) | WO2005120572A1 (https=) |
| ZA (1) | ZA200610239B (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2454974T3 (es) | 2007-06-27 | 2014-04-14 | The General Hospital Corporation | Aparato para la inhibición óptica de la terapia fotodinámica |
| AU2008337067A1 (en) * | 2007-12-14 | 2009-06-25 | Photoderma Sa | Novel compounds useful in therapeutic and cosmetic methods |
| WO2009093144A2 (en) * | 2008-01-25 | 2009-07-30 | Qlt, Inc.Lau | Photodynamic therapy of sebaceous gland disorders |
| FR2927800A1 (fr) * | 2008-02-25 | 2009-08-28 | Oreal | Association d'un rayonnement lumineux et d'un compose bioconvertible par la lipase pour ameliorer l'apparence de la peau et/ou du cheveu. |
| JP5808107B2 (ja) | 2008-12-17 | 2015-11-10 | 学校法人慶應義塾 | 細胞特異的能動集積性を有する光線力学療法剤 |
| BR112013017953A2 (pt) * | 2011-01-13 | 2017-08-29 | Quadra Logic Tech Inc | Composição farmacêutica, formulação tópica, método, e, composição fotossensibilizadora |
| EP2794004B1 (en) * | 2011-12-19 | 2020-07-29 | Photocure ASA | Irradiation apparatus |
| HU230989B1 (hu) * | 2013-01-17 | 2019-08-28 | Gd Photonics Kft. | Készítmény az UVB-fényterápia hatékonyságának fokozására, eljárás annak előállítására és alkalmazása |
| JP6595484B2 (ja) * | 2013-12-20 | 2019-10-23 | ガルデルマ・リサーチ・アンド・デヴェロップメント | 光損傷皮膚のパルス光力学的処置 |
| ES2860807T3 (es) | 2015-10-15 | 2021-10-05 | Dusa Pharmaceuticals Inc | Iluminador ajustable para terapia y diagnóstico fotodinámicos |
| US10603508B2 (en) | 2015-10-15 | 2020-03-31 | Dusa Pharmaceuticals, Inc. | Adjustable illuminators and methods for photodynamic therapy and diagnosis |
| US11331304B2 (en) | 2016-05-11 | 2022-05-17 | The Jackson Laboratory | YAP1 inhibitors and methods |
| US10357567B1 (en) | 2018-01-12 | 2019-07-23 | Dusa Pharmaceuticals, Inc. | Methods for photodynamic therapy |
| EP3989960A4 (en) * | 2019-06-25 | 2023-06-28 | Dusa Pharmaceuticals, Inc. | Methods for reducing pain during photodynamic therapy of actinic keratosis |
| FR3109086B1 (fr) | 2020-04-14 | 2025-10-24 | Ifremer | utilisation d’un extrait polaire de Skeletonema dans une thérapie photodynamique |
| AU2024295226A1 (en) | 2023-07-07 | 2026-02-12 | Fermentalg | Red algae biomass extract, and cosmetic use thereof for eliminating skin imperfections |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5171749A (en) | 1987-01-20 | 1992-12-15 | University Of British Columbia | Wavelength-specific cytotoxic agents |
| US5095030A (en) | 1987-01-20 | 1992-03-10 | University Of British Columbia | Wavelength-specific cytotoxic agents |
| GB8805849D0 (en) | 1988-03-11 | 1988-04-13 | Efamol Holdings | Porphyrins & cancer treatment |
| US5955490A (en) | 1989-07-28 | 1999-09-21 | Queen's University At Kingston | Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins |
| US6492420B2 (en) * | 1995-03-10 | 2002-12-10 | Photocure As | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| IL116126A0 (en) | 1995-11-24 | 1996-01-31 | Yeda Res & Dev | Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them |
| US6004821A (en) | 1998-03-07 | 1999-12-21 | Levine; Robert A. | Method and apparatus for performing chemical, qualitative, quantitative, and semi-quantitative analyses of a urine sample |
| AU4645099A (en) | 1998-07-09 | 2000-02-01 | Yoram Harth | Apparatus and method for efficient high energy photodynamic therapy of acne vulgaris and seborrhea |
| US6887260B1 (en) * | 1998-11-30 | 2005-05-03 | Light Bioscience, Llc | Method and apparatus for acne treatment |
| US6183773B1 (en) * | 1999-01-04 | 2001-02-06 | The General Hospital Corporation | Targeting of sebaceous follicles as a treatment of sebaceous gland disorders |
| IL133253A0 (en) | 1999-12-01 | 2001-04-30 | Yeda Res & Dev | Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| GB0005855D0 (en) | 2000-03-10 | 2000-05-03 | Scotia Holdings Plc | Compounds for pdt |
| GB2360459B (en) | 2000-03-23 | 2002-08-07 | Photo Therapeutics Ltd | Therapeutic light source and method |
| GB2361430A (en) | 2000-04-17 | 2001-10-24 | Photo Therapeutics Ltd | Therapeutic discharge lamps |
| EP2269645A3 (en) | 2000-08-16 | 2011-01-12 | The General Hospital Corporation doing business as Massachusetts General Hospital | Topical aminolevulinic acid-photodynamic therapy for acne vulgaris |
| US6984395B2 (en) * | 2001-04-11 | 2006-01-10 | Qlt, Inc. | Drug delivery system for hydrophobic drugs |
| US7018396B2 (en) * | 2001-08-07 | 2006-03-28 | New England Medical Center Hospitals, Inc. | Method of treating acne |
| CA2466425A1 (en) | 2001-11-09 | 2003-05-15 | Qlt Inc. | Photodynamic therapy for the treatment of hair loss |
| AU2003230808A1 (en) | 2002-04-05 | 2003-10-27 | Candela Corporation | High fluence rate activation of photosensitizers for dermatological applications |
| CA2457214A1 (en) * | 2004-02-06 | 2005-08-06 | Qlt Inc. | Photodynamic therapy for the treatment of acne |
-
2005
- 2005-02-08 JP JP2007526135A patent/JP2008501727A/ja active Pending
- 2005-02-08 CA CA002568744A patent/CA2568744A1/en not_active Abandoned
- 2005-02-08 WO PCT/CA2005/000154 patent/WO2005120572A1/en not_active Ceased
- 2005-02-08 AU AU2005251395A patent/AU2005251395A1/en not_active Abandoned
- 2005-02-08 EP EP05714425A patent/EP1755676B1/en not_active Expired - Lifetime
- 2005-02-08 BR BRPI0511897-2A patent/BRPI0511897A/pt not_active IP Right Cessation
- 2005-02-08 ES ES05714425T patent/ES2400566T3/es not_active Expired - Lifetime
- 2005-02-08 MX MX2007000338A patent/MX2007000338A/es active IP Right Grant
- 2005-02-08 DK DK05714425.5T patent/DK1755676T3/da active
- 2005-02-08 NZ NZ551636A patent/NZ551636A/en not_active IP Right Cessation
-
2006
- 2006-12-06 ZA ZA200610239A patent/ZA200610239B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1755676A1 (en) | 2007-02-28 |
| EP1755676A4 (en) | 2010-12-22 |
| MX2007000338A (es) | 2007-03-28 |
| DK1755676T3 (da) | 2013-02-18 |
| WO2005120572A1 (en) | 2005-12-22 |
| ES2400566T3 (es) | 2013-04-10 |
| NZ551636A (en) | 2009-12-24 |
| CA2568744A1 (en) | 2005-12-22 |
| AU2005251395A1 (en) | 2005-12-22 |
| EP1755676B1 (en) | 2012-11-28 |
| JP2008501727A (ja) | 2008-01-24 |
| ZA200610239B (en) | 2008-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0511897A (pt) | método para tratar distúrbios de glándula sebácea hiperativa, e, uso de uma composição fotossensibilizadora hidrofóbica e/ou lipofìlica | |
| BRPI0507406A (pt) | método de tratamento de acne vulgaris, e, uso de um fotossensibilizante de porfirina verde e solubilizador | |
| Darlenski et al. | Photodynamic therapy in dermatology: past, present, and future | |
| Gerritsen et al. | Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy | |
| Forster et al. | Penetration enhancement of two topical 5‐aminolaevulinic acid formulations for photodynamic therapy by erbium: YAG laser ablation of the stratum corneum: continuous versus fractional ablation | |
| Lopez et al. | Enhanced Delivery of 5‐Aminolevulinic Acid Esters by Iontophoresis In Vitro¶ | |
| Issa et al. | Topical delivery of triamcinolone via skin pretreated with ablative radiofrequency: a new method in hypertrophic scar treatment | |
| Fink-Puches et al. | Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light | |
| Genina et al. | Low-intensity indocyanine-green laser phototherapy of acne vulgaris: pilot study | |
| Angelo et al. | Chemical and physical strategies in onychomycosis topical treatment: A review | |
| Ross | Optical treatments for acne | |
| Cho et al. | Therapeutic efficacy and safety of a 1927-nm fractionated thulium laser on pattern hair loss: an evaluator-blinded, split-scalp study | |
| BR0214004A (pt) | Composição, uso da mesma, métodos de tratamento de alopecia androgenética, cânceres da pele, acne, ou para promover o crescimento dos pêlos, e de terapia fotodinâmica, e, processo da fabricação de uma composição | |
| JP2021183632A (ja) | 光損傷皮膚のパルス光力学的処置 | |
| FR2924021B1 (fr) | Composition pour le traitement de la peau par therapie photodynamique | |
| Gupta et al. | Medical devices for the treatment of onychomycosis | |
| BR0213996A (pt) | Método e aparelho para estimular o crescimento capilar | |
| Samy et al. | Effect of methylene blue-mediated photodynamic therapy for treatment of basal cell carcinoma | |
| Togsverd‐Bo et al. | Protoporphyrin IX formation and photobleaching in different layers of normal human skin: Methyl‐and hexylaminolevulinate and different light sources | |
| WO2000028971A1 (de) | 5-aminolävulinsäure-nanoemulsion | |
| Balakirski et al. | Photodynamic therapy in dermatology: established and new indications | |
| Huang et al. | Transdermal delivery of three vitamin C derivatives by Er: YAG and carbon dioxide laser pretreatment | |
| de Carvalho et al. | Effect of laser (λ 660 nm) and LED (λ 630 nm) photobiomodulation on formocresol-induced oral ulcers: a clinical and histological study on rodents | |
| Kittigul et al. | The efficacy of LED microneedle patch on hair growth in mice | |
| Nouri et al. | Light/laser therapy in the treatment of acne vulgaris |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |